Who decides which treatments you can access—and at what cost? Ways2Well founder Brigham Buhler joins Dr. Josh Axe to discuss pharmacy benefit managers, prescription pricing, and his fight for peptide access. They explore his FDA testimony, the debate over BPC-157 and GLP-1 medications, and his clinic’s use of plasma exchange and ozone therapy.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Podden och tillhörande omslagsbild på den här sidan tillhör
Dr. Josh Axe. Innehållet i podden är skapat av Dr. Josh Axe och inte av,
eller tillsammans med, Poddtoppen.
